Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-25-002316
Filing Date
2025-02-10
Accepted
2025-02-10 12:59:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6728
  Complete submission text file 0001214659-25-002316.txt   8429
Mailing Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016
Business Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016 212-601-9792
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

EIN.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92974 | Film No.: 25604803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)